2012 Drugs that promote or inhibit coagulation

Direct thrombin inhibitors : ARGATROBAN, BIVALIRUDIN, DABIGATRAN, HIRUDIN, LEPIRUDIN

Therapeutic Uses

The primary approved use of DTIs is for the treatment of heparin-induced thrombocytopenia (HIT). It is thought that DTIs will eventually replace both HEPARIN and WARFARIN as the anticoagulants of choice in many clinical scenarios.
Critical fact icon
Email: Dr. Janet Fitzakerley | ©2012 University of Minnesota Medical School Duluth | Last modified: 31-may-12 7:25 PM